Javascript must be enabled to continue!
Improving maternal and neonatal outcomes among pregnant women who are HIV-positive or HIV-negative through the Saving Mothers Giving Life initiative in Uganda: An analysis of population-based mortality surveillance data
View through CrossRef
HIV infection is associated with poor maternal health outcomes. In 2016, the maternal mortality ratio (MMR) in Uganda was 336/100,000, and the neonatal mortality rate (NMR) was 19/1,000. Saving Mothers, Giving Life (SMGL) was a five-year maternal and neonatal health strengthening initiative launched in 2012 in Uganda. We extracted maternal and neonatal data for 2015–2016 from the initiative’s population-based mortality surveillance system in 123 health facilities in Western Uganda. We collected data on the facilities, HIV status, antiretroviral drug (ARV) use, death, birth weight, delivery type, parity, Apgar scores, and complications. We compared mother and baby outcomes between HIV-positive or HIV-negative, computed risk ratios (RR) for adverse outcomes, and used the chi-square to test for significance in differences observed. Among 116,066 pregnant women who attended and gave birth at SMGL-implementing facilities during 2015–2016, 8,307 (7.7%) were HIV-positive, of whom 7,809 (94%) used antiretroviral drugs (ARVs) at the time of delivery. During birth, 23,993 (21%) women experienced ≥1 complications. Neonate Apgar scores <7 (8.8%) and maternal haemorrhage during birth (1.6%) were the most common outcomes. Overall facility MMR was 258/100,000 and NMR was 7.6/1,000. HIV infection increased risk of maternal death (RR = 3.6, 95% Confidence Interval (CI) = 2.4–5.5), maternal sepsis (RR = 2.1, 95% CI = 1.3–3.3), and infant birth weight <2,500g (RR = 1.2, 95% CI = 1.1–1.3), but was protective against maternal complications (RR = 0.92, 95% CI = 0.87–0.97) and perinatal death (RR = 0.78, 95% CI = 0.68–0.89). Among the HIV-positive, ARV non-use increased risk of maternal death (RR = 15, 95% CI = 7.1–31) and perinatal death (RR = 2.3, 95% CI = 1.6–3.4). SMGL reduced facility MMR and NMR below national rates. HIV-infection was associated with maternal sepsis and death. Failure to use ARVs among women living with HIV increased the risk of maternal and perinatal death. Use of the SMGL approach and complementary interventions that further strengthen HIV care, may continue to reduce MMR and NMR.
Public Library of Science (PLoS)
Title: Improving maternal and neonatal outcomes among pregnant women who are HIV-positive or HIV-negative through the Saving Mothers Giving Life initiative in Uganda: An analysis of population-based mortality surveillance data
Description:
HIV infection is associated with poor maternal health outcomes.
In 2016, the maternal mortality ratio (MMR) in Uganda was 336/100,000, and the neonatal mortality rate (NMR) was 19/1,000.
Saving Mothers, Giving Life (SMGL) was a five-year maternal and neonatal health strengthening initiative launched in 2012 in Uganda.
We extracted maternal and neonatal data for 2015–2016 from the initiative’s population-based mortality surveillance system in 123 health facilities in Western Uganda.
We collected data on the facilities, HIV status, antiretroviral drug (ARV) use, death, birth weight, delivery type, parity, Apgar scores, and complications.
We compared mother and baby outcomes between HIV-positive or HIV-negative, computed risk ratios (RR) for adverse outcomes, and used the chi-square to test for significance in differences observed.
Among 116,066 pregnant women who attended and gave birth at SMGL-implementing facilities during 2015–2016, 8,307 (7.
7%) were HIV-positive, of whom 7,809 (94%) used antiretroviral drugs (ARVs) at the time of delivery.
During birth, 23,993 (21%) women experienced ≥1 complications.
Neonate Apgar scores <7 (8.
8%) and maternal haemorrhage during birth (1.
6%) were the most common outcomes.
Overall facility MMR was 258/100,000 and NMR was 7.
6/1,000.
HIV infection increased risk of maternal death (RR = 3.
6, 95% Confidence Interval (CI) = 2.
4–5.
5), maternal sepsis (RR = 2.
1, 95% CI = 1.
3–3.
3), and infant birth weight <2,500g (RR = 1.
2, 95% CI = 1.
1–1.
3), but was protective against maternal complications (RR = 0.
92, 95% CI = 0.
87–0.
97) and perinatal death (RR = 0.
78, 95% CI = 0.
68–0.
89).
Among the HIV-positive, ARV non-use increased risk of maternal death (RR = 15, 95% CI = 7.
1–31) and perinatal death (RR = 2.
3, 95% CI = 1.
6–3.
4).
SMGL reduced facility MMR and NMR below national rates.
HIV-infection was associated with maternal sepsis and death.
Failure to use ARVs among women living with HIV increased the risk of maternal and perinatal death.
Use of the SMGL approach and complementary interventions that further strengthen HIV care, may continue to reduce MMR and NMR.
Related Results
Pregnant Prisoners in Shackles
Pregnant Prisoners in Shackles
Photo by niu niu on Unsplash
ABSTRACT
Shackling prisoners has been implemented as standard procedure when transporting prisoners in labor and during childbirth. This procedure ensu...
Playing Pregnancy: The Ludification and Gamification of Expectant Motherhood in Smartphone Apps
Playing Pregnancy: The Ludification and Gamification of Expectant Motherhood in Smartphone Apps
IntroductionLike other forms of embodiment, pregnancy has increasingly become subject to representation and interpretation via digital technologies. Pregnancy and the unborn entity...
The Women Who Don’t Get Counted
The Women Who Don’t Get Counted
Photo by Hédi Benyounes on Unsplash
ABSTRACT
The current incarceration facilities for the growing number of women are depriving expecting mothers of adequate care cruci...
Predictors of False-Negative Axillary FNA Among Breast Cancer Patients: A Cross-Sectional Study
Predictors of False-Negative Axillary FNA Among Breast Cancer Patients: A Cross-Sectional Study
Abstract
Introduction
Fine-needle aspiration (FNA) is commonly used to investigate lymphadenopathy of suspected metastatic origin. The current study aims to find the association be...
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
A infecção pelo vírus do HIV pode ocorrer de diversas maneiras, tendo sua principal forma a via sexual por meio do sexo desprotegido. O vírus do HIV fica em um período de incubação...
Comparative Study of Placental Malaria in HIV-positive and HIV- Negative Pregnant Women in Enugu, South-Eastern Nigeria
Comparative Study of Placental Malaria in HIV-positive and HIV- Negative Pregnant Women in Enugu, South-Eastern Nigeria
Background: Malaria and HIV/AIDS are two of the most devastating global health problems of our time. Available evidences have shown that HIV/AIDS increases the risk of clinical mal...
Laboratory-based Evaluation of Wondfo HIV1/2 Rapid Test Kits in the Gambia, December 2020
Laboratory-based Evaluation of Wondfo HIV1/2 Rapid Test Kits in the Gambia, December 2020
Background: HIV rapid diagnosis in The Gambia is mainly done using Determine HIV-1/2 and First Response HIV 1.2.0 or SD Bioline HIV-1/2 3.0 for screening and sero-typing of HIV res...
Association between maternal HIV infection and the risks of preterm birth and low birth weight in Chengdu, China: a propensity score matching approach
Association between maternal HIV infection and the risks of preterm birth and low birth weight in Chengdu, China: a propensity score matching approach
ObjectivesTo estimate the effect of HIV infection on the risk of preterm birth (PTB) and low birth weight (LBW) among Chinese pregnancy women.DesignA retrospective cohort study inc...

